Patents by Inventor Anil K. Sood

Anil K. Sood has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS RELATED TO PREFOLDIN AND ITS REGULATION
    Publication number: 20120070486
    Abstract: The present invention relates to the fields of molecular biology and drug delivery. In certain embodiments, the present invention provides methods for the delivery of a siNA (e.g., a siRNA) to a cell to modulate expression of a PFDN 1-6. These methods may be used to treat a disease, such as cancer.
    Type: Application
    Filed: February 12, 2008
    Publication date: March 22, 2012
    Inventors: Anil K. Sood, Rosemarie Schmandt, Gabriel Lopez-Berestein
  • HDL Particles for Delivery of Nucleic Acids
    Publication number: 20110312899
    Abstract: Disclosed are high density lipoprotein-nucleic acid particles, wherein the particles include (a) an apolipoprotein; (b) a nucleic acid component comprising a therapeutic nucleic acid segment; and (c) a polypeptide comprising a positively charged region, wherein the positively-charged region of the polypeptide associates with the nucleic acid component. Also disclosed are pharmaceutical compositions that include a) an apolipoprotein; (b) a nucleic acid component comprising a therapeutic nucleic acid segment; and (c) a polypeptide comprising a positively charged region. Methods that concern the particles and pharmaceutical compositions of the present invention are also set forth, as well as kits.
    Type: Application
    Filed: November 17, 2009
    Publication date: December 22, 2011
    Applicants: UNT HEALTH SCIENCE CENTER AT FORT WORTH, BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Anil K. Sood, Andras G. Lacko, Gabriel Lopez-Berestein, Lingegowda S. Mangala, Walter J. McConathy, Laszlo Prokai, Maya P. Nair
  • Therapeutic targeting of interleukins using siRNA in neutral liposomes
    Patent number: 8067390
    Abstract: The present invention relates to the fields of molecular biology and drug delivery. In certain embodiments, the present invention provides compositions that include an siRNA targeted to an interleukin and a neutral lipid, and methods of treating a human subject with cancer involving administering to the subject a pharmaceutically effective amount of an interleukin-8 antagonist or a composition as set forth herein.
    Type: Grant
    Filed: February 29, 2008
    Date of Patent: November 29, 2011
    Assignee: The Board of Regents of the University of Texas System
    Inventors: William M. Merritt, Anil K. Sood, Menashe Bar-Eli, Gabriel Lopez-Berestein
  • THERAPEUTIC TARGETING OF INTERLEUKINS USING SIRNA IN NEUTRAL LIPOSOMES
    Publication number: 20100172962
    Abstract: The present invention relates to the fields of molecular biology and drug delivery. In certain embodiments, the present invention provides compositions that include an siRNA targeted to an interleukin and a neutral lipid, and methods of treating a human subject with cancer involving administering to the subject a pharmaceutically effective amount of an interleukin-8 antagonist or a composition as set forth herein.
    Type: Application
    Filed: February 29, 2008
    Publication date: July 8, 2010
    Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: William M. Merritt, Anil K. Sood, Menashe Bar-Eli, Gabriel Lopez-Berestein
  • Delivery of Sirna by Neutral Lipid Compositions
    Publication number: 20090012021
    Abstract: The present invention relates to the fields of molecular biology and drug delivery. In certain embodiments, the present invention provides methods for the delivery of a siNA (e.g., a siRNA) to a cell via a neutral (non-charged) liposome. These methods may be used to treat a disease, such as cancer.
    Type: Application
    Filed: April 17, 2006
    Publication date: January 8, 2009
    Inventors: Anil K. Sood, Gabriel Lopez-Berestein, Charles N. Landen, Arturo Chavez-Reyes